Genetic Differences in Transcript Responses to Low-Dose Ionizing Radiation Identify Tissue Functions Associated with Breast Cancer Susceptibility

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Snijders, Antoine M ^a   Marchetti, Francesco ^a,b   Bhatnagar, Sandhya ^a   Duru, Nadire ^a   Han, Ju ^a   Hu, Zhi ^a,c   Mao, Jian Hua ^a   Gray, Joe W ^a,c   Wyrobek, Andrew J ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b HEALTH CANADA   (Canada)

^c Oregon Health and Science University Department of Biomedical Engineering   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BLOOD; BREAST CANCER; C57BL 6 MOUSE; CANCER PATIENT; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CELL AGING; CELL PROLIFERATION; CELLULAR STRESS RESPONSE; CHROMOSOME DAMAGE; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE; GENE EXPRESSION; GENETIC DIFFERENCE; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; IMMUNE RESPONSE; IONIZING RADIATION; LOW ENERGY RADIATION; MAMMARY GLAND; MOUSE; MOUSE STRAIN; NONHUMAN; PREDICTION; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; STRESS RESPONSE GENE; TISSUE REACTION; TISSUE SECTION; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE;

ANIMALS; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOMIC INSTABILITY; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RADIATION, IONIZING; RNA, MESSENGER; SURVIVAL ANALYSIS; TRANSCRIPTION, GENETIC; TUMOR MICROENVIRONMENT;

EID: 84867503923     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045394     Document Type: Article

References (61)

1. Mole RH, (1978) The sensitivity of the human breast to cancer induction by ionizing radiation. Br J Radiol 51: 401-405.
2. Boice JD Jr, Harvey EB, Blettner M, Stovall M, Flannery JT, (1992) Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326: 781-785.
3. Hancock SL, Tucker MA, Hoppe RT, (1993) Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85: 25-31.
4. Coleman MA, Yin E, Peterson LE, Nelson D, Sorensen K, et al. (2005) Low-dose irradiation alters the transcript profiles of human lymphoblastoid cells including genes associated with cytogenetic radioadaptive response. Radiat Res 164: 369-382.
5. Lowe XR, Bhattacharya S, Marchetti F, Wyrobek AJ, (2009) Early brain response to low-dose radiation exposure involves molecular networks and pathways associated with cognitive functions, advanced aging and Alzheimer's disease. Radiat Res 171: 53-65.
6. Nguyen DH, Oketch-Rabah HA, Illa-Bochaca I, Geyer FC, Reis-Filho JS, et al. (2011) Radiation Acts on the Microenvironment to Affect Breast Carcinogenesis by Distinct Mechanisms that Decrease Cancer Latency and Affect Tumor Type. Cancer Cell 19: 640-651.
7. Wyrobek AJ, Manohar CF, Krishnan VV, Nelson DO, Furtado MR, et al. (2011) Low dose radiation response curves, networks and pathways in human lymphoblastoid cells exposed from 1 to 10 cGy of acute gamma radiation. Mutat Res 722: 119-130.
8. (2006) Health Risks From Exposure to Low Levels of Ionizing Radiation BEIR VII Phase 2. Washington, DC: The National Academies Press.
9. Neumaier T, Swenson J, Pham C, Polyzos A, Lo AT, et al. (2011) Evidence for formation of DNA repair centers and dose-response nonlinearity in human cells. Proc Natl Acad Sci U S A 109: 443-448.
10. Ina Y, Tanooka H, Yamada T, Sakai K, (2005) Suppression of thymic lymphoma induction by life-long low-dose-rate irradiation accompanied by immune activation in C57BL/6 mice. Radiat Res 163: 153-158.
11. Olivieri G, Bodycote J, Wolff S, (1984) Adaptive response of human lymphocytes to low concentrations of radioactive thymidine. Science 223: 594-597.
12. Ullrich RL, Jernigan MC, Satterfield LC, Bowles ND, (1987) Radiation carcinogenesis: time-dose relationships. Radiat Res 111: 179-184.
13. Wolff S, (1998) The adaptive response in radiobiology: evolving insights and implications. Environ Health Perspect 106 (Suppl 1):: 277-283.
14. Storer JB, Mitchell TJ, Fry RJ, (1988) Extrapolation of the relative risk of radiogenic neoplasms across mouse strains and to man. Radiat Res 114: 331-353.
15. Yu Y, Okayasu R, Weil MM, Silver A, McCarthy M, et al. (2001) Elevated breast cancer risk in irradiated BALB/c mice associates with unique functional polymorphism of the Prkdc (DNA-dependent protein kinase catalytic subunit) gene. Cancer Res 61: 1820-1824.
16. Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, et al. (2007) Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 25: 1239-1246.
17. Pawitan Y, Bjohle J, Amler L, Borg AL, Egyhazi S, et al. (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 7: R953-964.
18. Abba MC, Lacunza E, Butti M, Aldaz CM, (2010) Breast cancer biomarker discovery in the functional genomic age: a systematic review of 42 gene expression signatures. Biomark Insights 5: 103-118.
19. McBryan J, Howlin J, Kenny PA, Shioda T, Martin F, (2007) ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis. Oncogene 26: 6406-6419.
20. Xu XL, Kapoun AM, (2009) Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbeta-responsive genes. J Transl Med 7: 12.
21. Dertinger SD, Torous DK, Tometsko KR, (1997) Flow cytometric analysis of micronucleated reticulocytes in mouse bone marrow. Mutat Res 390: 257-262.
22. Bhilwade HN, Chaubey RC, Chauhan PS, (2004) Gamma ray induced bone marrow micronucleated erythrocytes in seven strains of mouse. Mutat Res 560: 19-26.
23. Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, et al. (2007) An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28: 625-631.
24. Harris AL, (2002) Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47.
25. Leonard MO, Cottell DC, Godson C, Brady HR, Taylor CT, (2003) The role of HIF-1 alpha in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia. J Biol Chem 278: 40296-40304.
26. Jiang Y, Zhang W, Kondo K, Klco JM, St Martin TB, et al. (2003) Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways. Mol Cancer Res 1: 453-462.
27. Barcellos-Hoff MH, Dix TA, (1996) Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 10: 1077-1083.
28. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, et al. (2004) Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2: E7.
29. Johung K, Goodwin EC, DiMaio D, (2007) Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J Virol 81: 2102-2116.
30. Wu Q, Kirschmeier P, Hockenberry T, Yang TY, Brassard DL, et al. (2002) Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells. J Biol Chem 277: 36329-36337.
31. Hanley KP, Oakley F, Sugden S, Wilson DI, Mann DA, et al. (2008) Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J Biol Chem 283: 14063-14071.
32. Furuyama K, Kawaguchi Y, Akiyama H, Horiguchi M, Kodama S, et al. (2011) Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 43: 34-41.
33. Furuya M, Horiguchi J, Nakajima H, Kanai Y, Oyama T, (2012) Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis. Cancer Sci.
34. Helms MW, Kemming D, Pospisil H, Vogt U, Buerger H, et al. (2008) Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease. Br J Cancer 99: 774-780.
35. Liu ZB, Wu J, Ping B, Feng LQ, Di GH, et al. (2009) Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype. Tumori 95: 53-62.
36. McGowan PM, Duffy MJ, (2008) Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database. Ann Oncol 19: 1566-1572.
37. Ou K, Kesuma D, Ganesan K, Yu K, Soon SY, et al. (2006) Quantitative profiling of drug-associated proteomic alterations by combined 2-nitrobenzenesulfenyl chloride (NBS) isotope labeling and 2DE/MS identification. J Proteome Res 5: 2194-2206.
38. Symmans WF, Fiterman DJ, Anderson SK, Ayers M, Rouzier R, et al. (2005) A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding. Endocr Relat Cancer 12: 1059-1069.
39. Cheng AS, Culhane AC, Chan MW, Venkataramu CR, Ehrich M, et al. (2008) Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res 68: 1786-1796.
40. Emery LA, Tripathi A, King C, Kavanah M, Mendez J, et al. (2009) Early dysregulation of cell adhesion and extracellular matrix pathways in breast cancer progression. Am J Pathol 175: 1292-1302.
41. Hu Z, Fan C, Livasy C, He X, Oh DS, et al. (2009) A compact VEGF signature associated with distant metastases and poor outcomes. BMC Med 7: 9.
42. Pedraza V, Gomez-Capilla JA, Escaramis G, Gomez C, Torne P, et al. (2010) Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness. Cancer 116: 486-496.
43. Yu K, Ganesan K, Tan LK, Laban M, Wu J, et al. (2008) A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers. PLoS Genet 4: e1000129.
44. Ullrich RL, Ponnaiya B, (1998) Radiation-induced instability and its relation to radiation carcinogenesis. Int J Radiat Biol 74: 747-754.
45. Selvanayagam CS, Davis CM, Cornforth MN, Ullrich RL, (1995) Latent expression of p53 mutations and radiation-induced mammary cancer. Cancer Res 55: 3310-3317.
46. Ponnaiya B, Cornforth MN, Ullrich RL, (1997) Radiation-induced chromosomal instability in BALB/c and C57BL/6 mice: the difference is as clear as black and white. Radiat Res 147: 121-125.
47. Shankar B, Premachandran S, Bharambe SD, Sundaresan P, Sainis KB, (1999) Modification of immune response by low dose ionizing radiation: role of apoptosis. Immunol Lett 68: 237-245.
48. Gold LI, (1999) The role for transforming growth factor-beta (TGF-beta) in human cancer. Crit Rev Oncog 10: 303-360.
49. Bristow RG, Hill RP, (2008) Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8: 180-192.
50. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, et al. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59: 5830-5835.
51. Bonin F, Molina M, Malet C, Ginestet C, Berthier-Vergnes O, et al. (2009) GATA3 is a master regulator of the transcriptional response to low-dose ionizing radiation in human keratinocytes. BMC Genomics 10: 417.
52. Rodier F, Campisi J, (2011) Four faces of cellular senescence. J Cell Biol 192: 547-556.
53. Agrawal-Singh S, Isken F, Agelopoulos K, Klein HU, Thoennissen NH, et al. (2011) Genome wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene. Blood.
54. Forzati (2012) CBX7 is a tumor suppressor in mice and humans. J Clin Invest.
55. Neumann CA, Fang Q, (2007) Are peroxiredoxins tumor suppressors? Curr Opin Pharmacol 7: 375-380.
56. Silva FP, Morolli B, Storlazzi CT, Anelli L, Wessels H, et al. (2003) Identification of RUNX1/AML1 as a classical tumor suppressor gene. Oncogene 22: 538-547.
57. Wang L, Brugge JS, Janes KA, (2011) Intersection of FOXO- and RUNX1-mediated gene expression programs in single breast epithelial cells during morphogenesis and tumor progression. Proc Natl Acad Sci U S A 108: E803-812.
58. Whitfield ML, George LK, Grant GD, Perou CM, (2006) Common markers of proliferation. Nat Rev Cancer 6: 99-106.
59. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98: 10869-10874.
60. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
61. Hem A, Smith AJ, Solberg P, (1998) Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink. Lab Anim 32: 364-368.